Alexander kovalenko
@alexanderkova275.bsky.social
Reposted by Alexander kovalenko
Hims and Hears walked back on its plans to launch a cheaper compounded version of the Wegovy pill after facing legal threats from Novo Nordisk and U.S. health authorities.
Hims & Hers Falls 14% After It Pulls Pulls Copycat Wegovy Pill—Novo Nordisk Up 8%
Hims and Hears walked back on its plans to launch a cheaper compounded version of the Wegovy pill after facing legal threats from Novo Nordisk and U.S. health authorities.
www.forbes.com
February 9, 2026 at 10:30 AM
Hims and Hears walked back on its plans to launch a cheaper compounded version of the Wegovy pill after facing legal threats from Novo Nordisk and U.S. health authorities.